


Searching News Database: SENSUS
HSMN NewsFeed - 17 Nov 2025
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
HSMN NewsFeed - 25 Feb 2021
Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support
Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support
HSMN NewsFeed - 22 Dec 2020
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
HSMN NewsFeed - 7 Oct 2019
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
HSMN NewsFeed - 8 May 2018
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 24 May 2017
Drain-Free Mastectomy with TissuGlu(R) Surgical Adhesive Presented at UK Breast Surgery Meeting
Drain-Free Mastectomy with TissuGlu(R) Surgical Adhesive Presented at UK Breast Surgery Meeting
HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
HSMN NewsFeed - 26 Jul 2016
NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
HSMN NewsFeed - 18 Aug 2014
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
HSMN NewsFeed - 2 Jun 2014
Myriad myPath(TM) Melanoma Test Improves the Reliability of Melanoma Diagnosis
Myriad myPath(TM) Melanoma Test Improves the Reliability of Melanoma Diagnosis
HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
HSMN NewsFeed - 22 Jan 2014
Evidence review shows positive results for Negative Pressure Wound Therapy (NPWT) on surgical incisions
Evidence review shows positive results for Negative Pressure Wound Therapy (NPWT) on surgical incisions
HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
HSMN NewsFeed - 11 Sep 2013
Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection
Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection
HSMN NewsFeed - 15 Jul 2013
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
HSMN NewsFeed - 29 Nov 2012
NeuroMetrix Completes 510(k) Clearance Process for SENSUS(TM) Pain Management System
NeuroMetrix Completes 510(k) Clearance Process for SENSUS(TM) Pain Management System
HSMN NewsFeed - 24 Apr 2012
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
HSMN NewsFeed - 12 Mar 2012
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
HSMN NewsFeed - 19 Sep 2011
OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
HSMN NewsFeed - 5 Apr 2011
Board of Directors of Wright Medical Group, Inc. Appoints Chairman David D. Stevens as Interim CEO
Board of Directors of Wright Medical Group, Inc. Appoints Chairman David D. Stevens as Interim CEO
HSMN NewsFeed - 15 Mar 2011
Incyte’s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
Incyte’s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
HSMN NewsFeed - 8 Feb 2011
Given Imaging's PillCam(R) COLON Now Reimbursable for Hospital Inpatient Use in Germany
Given Imaging's PillCam(R) COLON Now Reimbursable for Hospital Inpatient Use in Germany
HSMN NewsFeed - 17 Jan 2011
KCI V.A.C.(R) GranuFoam(TM) Bridge XG Dressing Aids in the Treatment of Pressure Ulcers
KCI V.A.C.(R) GranuFoam(TM) Bridge XG Dressing Aids in the Treatment of Pressure Ulcers
HSMN NewsFeed - 6 Jul 2010
Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN
Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN
HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
HSMN NewsFeed - 5 Jan 2010
NewCardio, Inc. Announces Successful Clinical Studies Validating CardioBip Technology
NewCardio, Inc. Announces Successful Clinical Studies Validating CardioBip Technology
HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
HSMN NewsFeed - 3 Dec 2009
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
HSMN NewsFeed - 23 Sep 2009
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
HSMN NewsFeed - 29 Jul 2009
Aspect Medical Systems and LiDCO Group Sign Exclusive U.S. Distribution and Licensing Agreement
Aspect Medical Systems and LiDCO Group Sign Exclusive U.S. Distribution and Licensing Agreement
HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
HSMN NewsFeed - 15 Jan 2009
CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
HSMN NewsFeed - 17 Sep 2008
Three Rivers Pharmaceuticals(R), LLC Obtains Additional Commercial Rights to Infergen(R) from Amgen Inc.
Three Rivers Pharmaceuticals(R), LLC Obtains Additional Commercial Rights to Infergen(R) from Amgen Inc.
HSMN NewsFeed - 5 Sep 2008
Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL
Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL
HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
HSMN NewsFeed - 18 Jun 2008
SCAI Creates New Council for Rising Interest in Interventional Therapies for Structural Heart Disease
SCAI Creates New Council for Rising Interest in Interventional Therapies for Structural Heart Disease
HSMN NewsFeed - 29 May 2008
Medline's Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008
Medline's Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008
HSMN NewsFeed - 27 May 2008
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
HSMN NewsFeed - 10 Apr 2008
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
HSMN NewsFeed - 31 Mar 2008
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
HSMN NewsFeed - 20 Mar 2008
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
HSMN NewsFeed - 20 Feb 2008
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
HSMN NewsFeed - 14 Jan 2008
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
HSMN NewsFeed - 8 Jan 2008
Journal of Urology Supplement Focuses on Focal Therapy as a Prostate Cancer Treatment
Journal of Urology Supplement Focuses on Focal Therapy as a Prostate Cancer Treatment
HSMN NewsFeed - 20 Dec 2007
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
HSMN NewsFeed - 20 Dec 2007
Cytori Appoints Richard J. Hawkins, Senior Life Science Executive, to Board of Directors
Cytori Appoints Richard J. Hawkins, Senior Life Science Executive, to Board of Directors
HSMN NewsFeed - 31 Oct 2007
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
HSMN NewsFeed - 29 Oct 2007
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
HSMN NewsFeed - 22 Aug 2007
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 30 Jul 2007
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
HSMN NewsFeed - 9 May 2007
Ablatherm-HIFU Localized Prostate Cancer Clinical Study Resumes at Virginia Urology Center
Ablatherm-HIFU Localized Prostate Cancer Clinical Study Resumes at Virginia Urology Center
HSMN NewsFeed - 2 May 2007
Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
HSMN NewsFeed - 11 Apr 2007
Mike Bernstein Appointed Vice President of Regulatory Affairs, DFB Branded Pharmaceuticals
Mike Bernstein Appointed Vice President of Regulatory Affairs, DFB Branded Pharmaceuticals
HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
HSMN NewsFeed - 22 Feb 2007
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
HSMN NewsFeed - 8 Feb 2007
Polyanalgesic Consensus Panel Issues New Guidelines for Pain Management via Intraspinal Infusion
Polyanalgesic Consensus Panel Issues New Guidelines for Pain Management via Intraspinal Infusion
HSMN NewsFeed - 6 Feb 2007
Abbott Statement Regarding CMS' Proposed Expansion of Coverage for Carotid Artery Stenting
Abbott Statement Regarding CMS' Proposed Expansion of Coverage for Carotid Artery Stenting
HSMN NewsFeed - 1 Feb 2007
Cardinal Health Complies With New FDA Glove Rule Two Years Ahead of Deadline
Cardinal Health Complies With New FDA Glove Rule Two Years Ahead of Deadline
HSMN NewsFeed - 19 Jan 2007
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
HSMN NewsFeed - 1 Nov 2006
Report Calls for Using Heated Chemotherapy after Colon Cancer Surgery to Optimize Patient Survival
Report Calls for Using Heated Chemotherapy after Colon Cancer Surgery to Optimize Patient Survival
HSMN NewsFeed - 5 Oct 2006
EDAP Launches RPP Service at Major German Hospital; Updates Progress of German Marketing
EDAP Launches RPP Service at Major German Hospital; Updates Progress of German Marketing
HSMN NewsFeed - 27 Jun 2006
Panel of Experts Updates Guidelines for Use of KCI's V.A.C.(R) Therapy on the Diabetic Foot
Panel of Experts Updates Guidelines for Use of KCI's V.A.C.(R) Therapy on the Diabetic Foot
HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
HSMN NewsFeed - 22 May 2006
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
HSMN NewsFeed - 8 May 2006
Thermo Electron and Fisher Scientific to Combine in Industry-Transforming Transaction
Thermo Electron and Fisher Scientific to Combine in Industry-Transforming Transaction
Additional items found! 109
Members Archive contains
109 additional stories matching:
SENSUS
(Password required)
SENSUS
(Password required)
